I get it why some may be tempted to sell but there is atleast one big news near term which has not been priced in yet- China approval, which can be expected any day now. Expert panel has given go-ahead ot his vaccine, its in administrative review stage. I believe with the latest delta surge in China, they dont want to delay a decision on this. $FOSUN PHARMA(02196)$ factory capacity is 1 billion doses so we're looking at$BioNTech SE(BNTX)$ $10-15 billion sales territory when that happens.